Apellis Pharmaceuticals, Inc. (18) | Uncategorized (5)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 25, 2021)
- Form of Capped Call Transaction Confirmation (Filed With SEC on May 7, 2020)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 27, 2020)
- Form of Capped Call Transaction Confirmation (Filed With SEC on September 16, 2019)
- Offer Letter, dated as of April 13, 2018, by and between the Registrant and Lukas Scheibler (Filed With SEC on May 7, 2019)
